Hirsutism: investigation and management

References

• Carmina E, Lobo RA. Hirsutism, alopecia and acne. In: Principles and Practice of Endocrinology and Metabolism (3rd Edition). Beckers KL (Ed.). Lippincott Publishing, PA, USA 991–1008 (2001).
   Google Scholar
• Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS) arguably the most common endocrinopathy is associated with significant morbidity in women. J. Clin. Endocrinol. Metab.84, 1897–1899 (1999).
   PubMed Web of Science ®Google Scholar
• Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab.21, 1440–1447 (1961).
   PubMed Web of Science ®Google Scholar
• Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology and management. Am. J. Obstet. Gynecol.140, 815–830 (1981).
   PubMed Web of Science ®Google Scholar
• Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am. J. Obstet. Gynecol.167, 1807–1812 (1992).
   PubMed Web of Science ®Google Scholar
• Carmina E. Prevalence of idiopathic hirsutism. Eur. J. Endocrinol.139, 421–423 (1998).
   PubMed Web of Science ®Google Scholar
• Azziz R, Waggoner WT, Ochoa T, Knochenauer ES, Boots LR. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil. Steril.70, 274–278 (1998).
   PubMed Web of Science ®Google Scholar
• Li L, Yang D, Chen X, Chen Y, Feng S, Wang L. Clinical and metabolic features of polycystic ovary syndrome. Int. J. Gynaecol. Obstet.97, 129–134 (2007).
   PubMed Web of Science ®Google Scholar
• Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rationale approach. In: Polycystic Ovary Syndrome. Dunaif A, Givens JR, Haseltine F, Merriam GR (Eds). Mass Blackwell Scientific Publications, MA, USA 377–384 (1992).
   Google Scholar
• Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril.81, 19–25 (2004).
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril.91, 456–488 (2009).
   PubMed Web of Science ®Google Scholar
• Carmina E. The spectrum of androgen excess disorders. Fertil. Steril.85, 1582–1585 (2006).
   PubMedGoogle Scholar
• Carmina E. Mild androgen disorders. Best Pract. Res. Clin. Endocrinol. Metab.20, 207–220 (2006).
   PubMedGoogle Scholar
• Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr. Rev.21, 347–362 (2000).
   PubMed Web of Science ®Google Scholar
• Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J. Clin. Endocrinol. Metab.91, 2–6 (2006).
   PubMed Web of Science ®Google Scholar
• Azziz R, Sanchez LA, Knochenhauer ES et al. Androgen excess in women: experience with over 1000 consecutive patients. J. Clin. Endocrinol. Metab.89, 453–462 (2004).
   PubMed Web of Science ®Google Scholar
• Martyn KA, Chang RJ, Ehrmann DA et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab.93, 1105–1120 (2008).
   PubMedGoogle Scholar
• Di Fede G, Mansueto P, Pepe I, Rini GB, Carmina E. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms. Fertil. Steril. DOI: 10.1016/j.fertnstert.2009.02.056 (2009) (Epub ahead of print).
   Google Scholar
• Carmina E, Lobo RA. Evaluation of hormonal status. In: Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management (6th Edition). Strauss JF 3rd, Barbieri RL (Eds). Elsevier-Saunders, USA 32, 801–823 (2009).
   Google Scholar
• Friedman CI, Schmidt GE, Kim MH, Powell J. Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am. J. Obstet. Gynecol.153, 44 (1985).
   PubMed Web of Science ®Google Scholar
• Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab.92, 405–413 (2007)
   PubMed Web of Science ®Google Scholar
• Rosner W. An extraordinary inaccurate assay for free testosterone is still with us. J. Clin. Endocrinol. Metab.86, :2903 (2001).
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. Do hyperandrogenic women with normal menses have polycystic ovary syndrome? Fertil. Steril.71, 319–322 (1999).
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women. J. Endocrinol. Invest.30, 111–116 (2007).
   PubMed Web of Science ®Google Scholar
• Salley KE, Wickham EP, Cheang KJ, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome – a position statement of the Androgen Excess Society. J. Clin. Endocrinol. Metab.92, 4546–4556 (2007).
   PubMed Web of Science ®Google Scholar
• Berneis K, Rizzo M, Hersberger M et al. Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome. Int. J. Clin. Pract.63, 56–62 (2009).
   PubMed Web of Science ®Google Scholar
• Jovanovic VP, Carmina E, Lobo RA. Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertil. Steril. DOI:10.1016/j.fertnstert.2009.04.021 (2009) (Epub ahead of print).
   Google Scholar
• Unluhizarci K, Karababa Y, Bayram F, Kelestimur F. The investigation of idiopathic hirsutism in patients with idiopathic hirsutism. J. Clin. Endocrinol. Metab.89, 2741–2744 (2004).
   PubMed Web of Science ®Google Scholar
• Frajndlich R, Spritzer PM. Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism. Fertil. Steril.83, 1561–1564 (2005).
   PubMedGoogle Scholar
• Carmina E. A risk-benefit assessment of pharmacological therapies for hirsutism. Drug Saf.24, 267–276 (2001).
   PubMedGoogle Scholar
• Kiddy DS, Hamilton-Fairley D, Bush A et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.)36, 105–111 (1992).
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome. Hum. Reprod. Update11, 277–291 (2005).
   PubMed Web of Science ®Google Scholar
• Guido M, Romualdi D, Giuliani M et al. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J. Clin. Endocrinol. Metab.89, 2817–2823 (2004).
   PubMed Web of Science ®Google Scholar
• Palep-Singh M, Barth JH, Mook K, Balen AH. An observation study of Yasmin in the management of polycystic ovary syndrome. J. Fam. Plan Repro. Health Care30, 163–165 (2004).
   PubMed Web of Science ®Google Scholar
• Moghetti C, Castello R, Negri C et al. Metformin effects on clinical features, endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo controlled 6-month trial, followed by open, long-term clinical evaluation. J. Clin. Endocrinol. Metab.85, 139–146 (2000).
   PubMed Web of Science ®Google Scholar
• Morin-Papunen LC, Koivunen RM, Ruokonen A, Martikeinen HK. Metformin improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil. Steril.69, 691–696 (1998).
   PubMed Web of Science ®Google Scholar
• Unluhizarci K, Ozel D, Tanriverdi F, Karaca Z, Kelestimur F. A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism. J. Endocrinol. Invest.32, 37–40 (2009).
   PubMedGoogle Scholar
• Fanta M, Hill M, Belácek J, Vrbíková J, Cibula D. Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: a prospective study. Gynecol.Endocrinol.25, 398–402 (2009).
   PubMed Web of Science ®Google Scholar
• Sanchez LA, Perez M, Azziz R. Laser hair reduction in the hirsute patient: a critical assessment. Hum. Reprod.8, 169–181 (2002).
   Google Scholar
• Carmina E. Topical eflornithine. A viewpoint. Am. J. Clin. Dermatol.2, 202 (2001).
   Google Scholar
• Carmina E, Lobo RA. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism. Obstet. Gynecol.18, 845–849 (1991).
   Google Scholar
• Carmina E, Lobo RA. The addiction of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission. Fertil. Steril.69, 1075–1079 (1998).
   PubMed Web of Science ®Google Scholar